应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
SVA 科兴生物
停牌 07-11 16:00:00 EDT
6.47
+0.00
0.00%
最高
6.47
最低
6.47
成交量
0.00
今开
6.47
昨收
6.47
日振幅
0.00%
总市值
3.89亿
流通市值
2.02亿
总股本
6,006万
成交额
0.00
换手率
0.00%
流通股本
3,117万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
一周医药速览（07.07-07.11）
财经网 · 07-11 08:27
一周医药速览（07.07-07.11）
科兴生物商业版图盘点
和讯网 · 07-10
科兴生物商业版图盘点
10位新董事上任，科兴生物特别股东大会通过赛富议案
广州日报 · 07-10
10位新董事上任，科兴生物特别股东大会通过赛富议案
科兴生物特别股东大会选举10位新董事；多家医药上市公司发半年度预增公告 | 医药早参
每日经济新闻 · 07-09
科兴生物特别股东大会选举10位新董事；多家医药上市公司发半年度预增公告 | 医药早参
科兴生物股权争夺最新进展：特别股东会投票罢免现任董事，改选赛富基金提名董事进入董事会
界面 · 07-09
科兴生物股权争夺最新进展：特别股东会投票罢免现任董事，改选赛富基金提名董事进入董事会
两大权威公司治理研究机构支持科兴生物现任董事会
南方财富网 · 07-08
两大权威公司治理研究机构支持科兴生物现任董事会
科兴生物计划进行总额最高约75亿美元“清仓式分红”
蓝鲸财经 · 07-07
科兴生物计划进行总额最高约75亿美元“清仓式分红”
科兴1500万元转让全资子公司股权，克癀胶囊从委托代工转向自产
山东财经头条 · 06-18
科兴1500万元转让全资子公司股权，克癀胶囊从委托代工转向自产
Prime Success致信Sinovac Biotech股东
美国商业资讯 · 06-12
Prime Success致信Sinovac Biotech股东
科兴制药：科益医药拟减持不超3%公司股份
澎湃新闻 · 06-04
科兴制药：科益医药拟减持不超3%公司股份
【未名医药：收到北京科兴分红款1.35亿元】未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。
金融界 · 05-16
【未名医药：收到北京科兴分红款1.35亿元】未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。
科兴生物：股权争夺与审计风波 8亿美元股息
和讯网 · 04-30
科兴生物：股权争夺与审计风波 8亿美元股息
科兴新董事会回应维梧资本“炮轰”
界面 · 04-30
科兴新董事会回应维梧资本“炮轰”
北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同
iDoNews · 04-29
北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同
新事 | 科兴生物被起诉
健识局 · 04-25
新事 | 科兴生物被起诉
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。
金融界 · 01-14
【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。
加载更多
公司概况
公司名称：
科兴生物
所属市场：
NASDAQ
上市日期：
--
主营业务：
科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立，是一家总部位于北京的生物高新技术企业。公司主要从事于研究，开发，制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗（完成I期临床研究）、中国第一支大流行流感（H5N1）疫苗以及全球第一支甲型H1N1流感疫苗，为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品，包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。
发行价格：
--
{"stockData":{"symbol":"SVA","market":"US","secType":"STK","nameCN":"科兴生物","latestPrice":6.47,"timestamp":1752264000000,"preClose":6.47,"halted":3,"volume":0,"delay":0,"floatShares":31169000,"shares":60060702,"eps":0.971025,"marketStatus":"停牌","change":0,"latestTime":"07-11 16:00:00 EDT","open":6.47,"high":6.47,"low":6.47,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.971025,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1102482000000,"exchange":"NASDAQ","adjPreClose":6.47,"volumeRatio":0.5219117885997689},"requestUrl":"/m/hq/s/SVA","defaultTab":"news","newsList":[{"id":"2550987149","title":"一周医药速览（07.07-07.11）","url":"https://stock-news.laohu8.com/highlight/detail?id=2550987149","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550987149?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:27","pubTimestamp":1752222452,"startTime":"0","endTime":"0","summary":"目前，市场上可用于小儿便秘的同类产品主要用于其他疾病伴发的便秘症状，临床尚无治疗小儿便秘的儿童专用中药创新药。甘李药业：预计上半年净利润增加100.73%到114.12%，胰岛素量价齐升甘李药业发布2025年半年度业绩预增公告。披露经财务部门初步测算，预计 2025 年半年度实现归属净利润为6亿元到6.4亿元，与上年同期相比，同比增加 100.73%到 114.12%。临床前多种动物模型研究结果显示，UBT37034与GLP-1类似物联用能显著降低体重。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711162815a44457d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","600566","BK4139","603087","03933","01801","SVA"],"gpt_icon":0},{"id":"2550619534","title":"科兴生物商业版图盘点","url":"https://stock-news.laohu8.com/highlight/detail?id=2550619534","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550619534?lang=zh_cn&edition=full","pubTime":"2025-07-10 15:21","pubTimestamp":1752132087,"startTime":"0","endTime":"0","summary":"天眼查App显示，科兴生物关联公司北京科兴生物制品有限公司成立于2001年4月，法定代表人为尹卫东，注册资本约1.41亿人民币，经营范围含药品生产、药品批发、药品进出口、医学研究和试验发展、货物进出口等。司法案件信息显示，该公司涉及多起案件，包括股东知情权纠纷、公司决议纠纷、医疗损害责任纠纷等。商业履历信息显示，科兴生物董事长尹卫东名下关联20余家企业，其中18家为存续状态，包括北京科兴益道医药有限公司、北京兴益鼎生物技术有限公司、科兴中维（海南）生物技术有限公司等，尹卫东在上述公司担任执行董事、法定代表人等。（责任编辑：刘静 HZ010）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710153612a441fc50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2550074618","title":"10位新董事上任，科兴生物特别股东大会通过赛富议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2550074618","media":"广州日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550074618?lang=zh_cn&edition=full","pubTime":"2025-07-10 14:41","pubTimestamp":1752129708,"startTime":"0","endTime":"0","summary":"7月9日，SAIFPartners（赛富投资基金）公告称，在科兴控股生物技术有限公司（简称“科兴生物”）特别股东大会上，股东投票通过了SAIFPartners提出的两项议案：罢免该公司现任董事，并选举SAIFPartners提名的10位资深董事候选人进入公司董事会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103453279939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550801661","title":"科兴生物特别股东大会选举10位新董事；多家医药上市公司发半年度预增公告 | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2550801661","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550801661?lang=zh_cn&edition=full","pubTime":"2025-07-10 07:21","pubTimestamp":1752103281,"startTime":"0","endTime":"0","summary":"丨2025年7月10日星期四丨NO.1甘李药业2025年半年度净利润预计翻番7月9日，甘李药业发布2025年半年度业绩预增公告，预计2025年半年度实现归母净利润6亿元到6.4亿元，同比增加100.73%到114.12%。公司表示主要受益于营业收入显著提升及费用的精细化管控。通过两轮胰岛素集采，公司成功实现扩大市场份额的战略目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507103452616428.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507103452616428.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK4139","BK1161","BK1574","SVA","09939"],"gpt_icon":0},{"id":"2550500529","title":"科兴生物股权争夺最新进展：特别股东会投票罢免现任董事，改选赛富基金提名董事进入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2550500529","media":"界面","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550500529?lang=zh_cn&edition=full","pubTime":"2025-07-09 14:05","pubTimestamp":1752041120,"startTime":"0","endTime":"0","summary":"7月9日，据赛富基金最新披露，在今早进行的科兴生物特别股东大会上，投票通过了赛富基金提出的两项提案：罢免公司现任董事，并选举由赛富提名的十位具备高度资质的董事候选人进入公司董事会。会议上，先由科兴生物现任董事长李嘉强主持召开特别会议，但随即宣布会议中止，并未给予股东参与表决的机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709140520a43f9677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709140520a43f9677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2550840578","title":"两大权威公司治理研究机构支持科兴生物现任董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2550840578","media":"南方财富网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550840578?lang=zh_cn&edition=full","pubTime":"2025-07-08 19:13","pubTimestamp":1751973180,"startTime":"0","endTime":"0","summary":"随着科兴生物的控股股东特别股东大会临近，国际知名公司治理研究与股东投票咨询和代理机构Institutional Shareholder Services Inc.与 Glass Lewis，于上周先后发布分析报告，一致建议科兴股东支持由李嘉强博士领导的现任董事会。也释放出一个清晰信号：专业机构普遍认为，维持科兴生物控股的现有董事会，有助于保障股东权益、推动公司恢复正常运作。这项分红举措获得两大机构一致认可，Glass Lewis评价现任董事会“在恢复治理稳定和运营正常化方面取得了可信的进展”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709033641953b35b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709033641953b35b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2549815615","title":"科兴生物计划进行总额最高约75亿美元“清仓式分红”","url":"https://stock-news.laohu8.com/highlight/detail?id=2549815615","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549815615?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:38","pubTimestamp":1751877531,"startTime":"0","endTime":"0","summary":"截至2024年6月，科兴生物现金储备约103亿美元，而三次分红总额约占现金的73%，故被市场称为“清仓式分红”。科兴生物还在公告中喊话，股东投票关系到能否如期获得补偿性股息。经香港高等法院于6月27日紧急聆讯，法庭拒绝授予其在传票所申请的任何救济措施。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1751876526133691941","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2544971781","title":"科兴1500万元转让全资子公司股权，克癀胶囊从委托代工转向自产","url":"https://stock-news.laohu8.com/highlight/detail?id=2544971781","media":"山东财经头条","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544971781?lang=zh_cn&edition=full","pubTime":"2025-06-18 19:21","pubTimestamp":1750245694,"startTime":"0","endTime":"0","summary":"对于转让的原因，科兴生物方面表示，此前，科兴生物委托同安医药开展克癀胶囊的生产，现在，该公司已经独立掌握该药品的生产技术。此次交易完成后，科兴生物不再持有同安医药股权。不过，今年前三个月，科兴制药营收再次出现下跌情况，实现营业收入3.54亿元，同比下降1.97%；净利润方面态势良好，实现2485.11万元，同比增长116.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618192756a7106ab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618192756a7106ab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2543545236","title":"Prime Success致信Sinovac Biotech股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2543545236","media":"美国商业资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543545236?lang=zh_cn&edition=full","pubTime":"2025-06-12 16:00","pubTimestamp":1749715200,"startTime":"0","endTime":"0","summary":"Prime Success目前持有公司约8%的流通股。Prime Success在公开信中阐述了Sinovac董事会进行改革的必要性，并列出了支持选举SAIF Partners IV L.P.提名董事候选人的关键理由。与Prime Success的上述承诺举措完全不同，Sinovac董事会现任成员：采取的行动导致并延长了2019年公司股票在NASDAQ停牌，这极大损害了Sinovac的发展。Prime Success坚信，支持SAIF提名的董事人选对Sinovac的未来发展至关重要，并呼吁全体股东在2025年7月8日特别股东大会投票前，务必审阅SAIF提供的委托材料。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613000112a4a58239&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613000112a4a58239&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QLD","NVIW.SI",".IXIC","MNQmain","SQQQ","TQQQ","USJW.SI","QID","PSQ","SVA","TSYW.SI","NQmain","USAW.SI","BK4139"],"gpt_icon":1},{"id":"2540065123","title":"科兴制药：科益医药拟减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2540065123","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540065123?lang=zh_cn&edition=full","pubTime":"2025-06-04 20:09","pubTimestamp":1749038940,"startTime":"0","endTime":"0","summary":"6月4日晚间，科兴生物制药股份有限公司公告，截至本公告披露日，深圳科益医药控股有限公司（以下简称“科益医药”）直接持有公司131,778,347股，占公司总股本的比例为66.01%。科益医药本次拟通过集中竞价或大宗交易方式减持所持有的公司股份为不超过5,989,200 股，即不超过公司目前股份总数的3.00%。本次减持计划自公告披露之日起15个交易日后的3个月内（根据中国证券监督管理委员会及上海证券交易所规定禁止减持的期间除外）进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604201853a6fa40a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2535391646","title":"【未名医药：收到北京科兴分红款1.35亿元】未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535391646","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535391646?lang=zh_cn&edition=full","pubTime":"2025-05-16 19:48","pubTimestamp":1747396098,"startTime":"0","endTime":"0","summary":"未名医药公告，近日公司收到参股公司北京科兴生物制品有限公司分红款项人民币1.35亿元。根据北京科兴董事会决议，按照各位股东在北京科兴注册资本中的出资比例对截至2024年12月31日累计可分配利润中的部分利润进行分配。公司持有北京科兴26.91%股权，可获得现金分红款人民币1.35亿元。截止本公告披露日，公司已收到上述全部现金分红款项。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16194850460076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","BK0046","BK0239","002581","BK0197","BK0077","SVA","BK0042"],"gpt_icon":0},{"id":"2531777680","title":"科兴生物：股权争夺与审计风波 8亿美元股息","url":"https://stock-news.laohu8.com/highlight/detail?id=2531777680","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531777680?lang=zh_cn&edition=full","pubTime":"2025-04-30 14:37","pubTimestamp":1745995069,"startTime":"0","endTime":"0","summary":"【4 月 29 日，国内著名疫苗厂商科兴生物与维梧资本陷纷争】科兴生物称维梧资本此前言论为虚假指控，维梧集团正通过诉讼等方式试图阻止公司向股东支付特别股息。科兴生物指出所有普通股股东过去七年分文未得，而维梧集团已从科兴一家控股子公司获超 8 亿美元现金股息。科兴生物认为维梧集团行为动机为谋财，其主张与法院裁决相悖。科兴生物的股权争夺战可追溯至 2016 年。维梧资本 4 月 24 日称已对科兴生物发起诉讼，审计师辞职致科兴生物无法按期提交年度报告。4 月 29 日科兴生物称审计师辞职原因在于无法依赖此前财务状况陈述，公司已增添审计委员会财务专家。（责任编辑：张晓波 ）","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430144525a6ce69b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2531724393","title":"科兴新董事会回应维梧资本“炮轰”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531724393","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531724393?lang=zh_cn&edition=full","pubTime":"2025-04-30 11:41","pubTimestamp":1745984501,"startTime":"0","endTime":"0","summary":"简单理解，维梧资本代表的是科兴生物前董事会的利益，科兴生物当前的发文代表的是新董事会的决策。维梧资本目前将1 Globe视为“激进投资人”，认为“1 Globe及其控制下的董事会（会）进一步采取破坏性行动”。在科兴生物4月29日发文之前，4月24日，维梧资本在公众号发文称，公司已对科兴生物董事会发起诉讼。维梧资本认为，科兴生物董事会在1Globe及其盟友控制下，采取了诸多不负责任行为。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430114459a46d18a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVIW.SI","BK4139","PSQ","SVA","TQQQ","ARTL","BK4007","QLD","QID","MNQmain","USJW.SI","TSYW.SI","USAW.SI","NQmain",".IXIC","SQQQ"],"gpt_icon":1},{"id":"2531001562","title":"北京科兴生物制品有限公司中标包头海关综合技术服务中心供货合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2531001562","media":"iDoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531001562?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:23","pubTimestamp":1745922182,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年04月28日，北京科兴生物制品有限公司中标包头海关综合技术服务中心的供货合同项目。该项目为海关总署2023-2024年出入境预防接种疫苗询价（重新招标）采购项目，合同金额为0.616000万元。合同主要信息显示，标的物为四价流感疫苗，规格型号为注射器包装，数量70个，单价88元。履约地点为内蒙古自治区包头市昆区少先路18号的包头海关综合技术服务中心，合同签订日期为2025年04月25日，公告类型为中标结果。免责声明：本文内容由开放的智能模型自动生成，仅供参考。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042918234894e760d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SVA"],"gpt_icon":0},{"id":"2530303180","title":"新事 | 科兴生物被起诉","url":"https://stock-news.laohu8.com/highlight/detail?id=2530303180","media":"健识局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530303180?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:08","pubTimestamp":1745582937,"startTime":"0","endTime":"0","summary":"4月28日，维梧资本发布公告称：公司已对科兴控股生物技术有限公司的发起诉讼。双方争论的焦点是：科兴生物改变董事会人选之后，管理层作出一系列变化引发公司治理危机。为此，维梧资本在美国多地高等法院对科兴生物提起诉讼，要求法院下令禁止1 Globe进一步违反美国证券法，并强制其披露关于科兴生物的计划和相关方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425202525a466d40b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SVA","BK4139"],"gpt_icon":0},{"id":"2503545080","title":"【科兴独家中标智利流感疫苗项目 首批疫苗将于明日发往智利】SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503545080","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503545080?lang=zh_cn&edition=full","pubTime":"2025-01-14 16:59","pubTimestamp":1736845176,"startTime":"0","endTime":"0","summary":"SINOVAC科兴中标智利项目新闻发布会上，科兴副总裁、国际业务负责人孟伟宁介绍，1月10号，SINOVAC科兴旗下北京科兴生物制品有限公司生产的三价流感疫苗安尔来福®独家中标了智利政府2025年年度流感疫苗的全球招标，首批疫苗将于1月15日发往智利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14165947435781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SVA","BK4139","159646"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinovac.com;www.sinovac.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"科兴控股生物技术有限公司于1999年3月1日在安提瓜和巴布达注册成立，是一家总部位于北京的生物高新技术企业。公司主要从事于研究，开发，制造及保护免受感染性疾病的疫苗。公司还曾先后研制出全球第一支SARS冠状病毒灭活疫苗（完成I期临床研究）、中国第一支大流行流感（H5N1）疫苗以及全球第一支甲型H1N1流感疫苗，为中国乃至全球疾病预防控制做出了贡献。公司正在开发一系列新产品，包括Sabin株脊髓灰质炎灭活疫苗、23价肺炎球菌多糖疫苗、新型冠状病毒灭活疫苗及多个联合疫苗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.027083},{"month":2,"riseRate":0.7,"avgChangeRate":0.044011},{"month":3,"riseRate":0.777778,"avgChangeRate":0.016157},{"month":4,"riseRate":0.111111,"avgChangeRate":-0.050461},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.034293},{"month":6,"riseRate":0.444444,"avgChangeRate":0.023452},{"month":7,"riseRate":0.2,"avgChangeRate":-0.024319},{"month":8,"riseRate":0.444444,"avgChangeRate":0.025862},{"month":9,"riseRate":0.666667,"avgChangeRate":0.007361},{"month":10,"riseRate":0.666667,"avgChangeRate":0.018455},{"month":11,"riseRate":0.666667,"avgChangeRate":0.055242},{"month":12,"riseRate":0.3,"avgChangeRate":-0.010006}],"exchange":"NASDAQ","name":"科兴生物","nameEN":"Sinovac Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴生物,SVA,科兴生物股票,科兴生物股票老虎,科兴生物股票老虎国际,科兴生物行情,科兴生物股票行情,科兴生物股价,科兴生物股市,科兴生物股票价格,科兴生物股票交易,科兴生物股票购买,科兴生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴生物(SVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴生物(SVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}